Page last updated: 2024-10-27

fluconazole and Purpura, Thrombocytopenic

fluconazole has been researched along with Purpura, Thrombocytopenic in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Purpura, Thrombocytopenic: Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ding, JZ1
Torres, C1

Other Studies

1 other study available for fluconazole and Purpura, Thrombocytopenic

ArticleYear
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2021, 07-05, Volume: 193, Issue:26

    Topics: Adult; Antifungal Agents; Cysts; Fluconazole; Humans; Immunocompromised Host; Immunosuppressive Agen

2021